You can use your existing Medical Independent, MediLearning or PharmacistCPD account to log in. is Ireland's only investigative medical news website for doctors, healthcare professionals and anyone with an interest in health issues.

Established in 2010, along with its sister publication The Medical Independent, our stated aim is to investigate and analyse the major issues affecting healthcare and the medical profession in Ireland. The Medical Independent has won a number of awards for its investigative journalism, and its stories are frequently picked up by national digital, broadcast and print media. The Medical Independent is published by GreenCross Publishing.

Address: Top Floor, 111 Rathmines Road Lr, Dublin 6

Tel: 353 (01) 441 0024

GreenCross Publishing is owned by Graham Cooke.

The benefits of registering: only registered users:
  • receive the ecCopy two days prior to the printed edition.
  • have automatic access to our free CPD sites.
  • can partake in our online MCQs.
  • can enter our online sports quiz.

Sign up now for ease of access to The Medical Independent, Ireland’s most frequently published medical newspaper, delivering award-winning news and investigative reporting.

Download the new Mindo app for both IOS & Android.

  • Get notified when a story goes live
  • Access Premium Content
  • Read Offline
[the_ad_placement id="main-ldb-public"]
[the_ad_placement id="main-ldb-mobile-public"]

You are reading 1 of 2 free-access articles allowed for 30 days

Objective pain measurement could be a ‘game-changer’ for patients

By Dermot - 22nd Oct 2019 | 8 views

New research into objective measurement of pain could be a ‘game-changer’ for patients, delegates at the European Pain Federation’s biennial Congress in Valencia, Spain, heard,

Until now, a patient’s experience of pain has always been subjective, relying upon their personal feeling and communication of the experience. However, a research project by the international consortium IMI-PainCare is aiming to identify biomarkers (such as proteins or hormones or pharmacodynamic measurements such as brain imaging) for pain to enable objective measurement. The Consortium is composed of 40 participants from 14 countries; six are EFPIA (European Federation of Pharmaceutical Industries and Associations) participants with strong traditions in pain research and development, 23 are internationally-renowned academic and clinical institutions, five are specialist SMEs with cutting-edge technologies, three are patient organisations, and three are professional pain/anaesthesia societies.

The project co-ordinator, Prof Rolf-Detlef Treede, the Chair of Neurophysiology at the Centre for Biomedicine and Medical Technology in Mannheim, Germany, presented the details and findings of the project to date at the EFIC Congress.

“Biomarkers for pain would be a complete game-changer, potentially providing us with an objective measurement of pain for the first time, allowing us to compare the severity of conditions and the efficacy of treatments and services,” said Prof Treede.

“If the same patient-reported outcomes are used universally, we will be better able to compare the performance of pain services and treatments across many types of pain condition,” he added. See for more information.

Leave a Reply

[the_ad_placement id="main-ldb-public-2"]
[the_ad_placement id="main-ldb-mobile-public-2"]
Latest Issue
The Medical Independent – 24 June 2021

You need to be logged in to access this content. Please login or sign up using the links below.

[the_ad_placement id="main-mpu-public"]
Most Read
[the_ad_placement id="main-ldb-public-2"]
[the_ad_placement id="main-ldb-mobile-public-2"]